BLOG/🇺🇸United States··daily

US SEC Filings Daily Market Digest — April 08, 2026

Daily USA Market Intelligence

20 high priority30 medium priority50 total filings analysed

Executive Summary

Across 50 SEC filings for April 8, 2026, dominant themes include robust capital allocation via dividends and buybacks in REITs (Kimco +4% YoY dividends, 6.1M shares repurchased), surging revenues in niche growth sectors like LNG (Venture Global +177% YoY to $13.8B) and refurbished electronics (ATRenew +28.9% YoY to profitability), contrasted by biotech headwinds (Nurix revenue -66% YoY, net loss widened to $87M). M&A momentum accelerates with FTC clearances (Day One tender at $21.50/share, CECO-Thermon HSR terminated), merger filings (Corebridge-Equitable all-stock deal targeting YE2026 close), and crypto mining approvals (Coeptis-Z Squared). Period-over-period trends show 4/7 key revenue reporters with >20% YoY growth (avg +79%), but cash burn in biotechs (Nurix cash -71% QoQ, SmartKem -95% YoY) and mixed cash flows (ATRenew operating cash -165% YoY). 13F-HR filings (14 total) reveal institutional tilt to tech megacaps (Apple, Amazon, NVIDIA ubiquitous) and ETFs, signaling defensive positioning. Forward catalysts cluster in Q2 2026 mergers and May proxy votes, with 2026-2027 pipelines in AI/autonomous (PlusAI $1B ARR target) and nuclear (Nano Nuclear UF6 facility). Overall, actionable alpha in energy/REITs amid biotech caution, with portfolio-level margin expansion in winners (Venture Global op income +192% YoY).

Tracking the trend? Catch up on the prior US SEC Filings Daily Market Digest digest from April 01, 2026.

Investment Signals(12)

  • 96.4% pro-rata occupancy at all-time high, +4% YoY dividends to $1.01/share, repurchased 6.1M shares at $19.79 avg, Net Debt/EBITDA stable at 5.4x with A-/A3 ratings

  • ATRenew(BULLISH)

    Revenues +28.9% YoY to RMB 21B ($3B), swung to net income RMB 336M from loss, adjusted net income +36% to RMB 428M despite cash flow deterioration

  • Revenues +177% YoY to $13.8B, op income +192% to $5.2B, net income +53% to $2.3B, Adj EBITDA +198% to $6.3B, assets +23% to $53.4B

  • Revenues +22% YoY to $32.4M, net income $3.2M vs $16M loss, Adj EBITDA +43% to $5.4M driven by indoor +34% and pre-rolls +57%

  • FTC early HSR termination on Apr 7, satisfies antitrust for $21.50/share tender offer per Mar 6 merger agreement

  • Nasdaq listing approval for post-merger Z Squared (Dogecoin miner) under ZSQR, expected Q2 2026 close

  • Closed $2M convertible preferred tranche (part of $20M commitment), fixed $0.55 conversion with 200% warrant coverage signaling investor confidence

  • Monthly dividend $0.08/share declared Apr 7, payable May 29 to Apr 30 record

  • Vistance Networks (CommScope)(BULLISH)

    Special $10/share cash distribution Apr 27 to Apr 17 record, funded by CCS sale proceeds avoiding leverage

  • PlusAI(BULLISH)

    $25M HyperFoundry revenue YTD targeting $40-50M FY2026, 92% autonomous coverage, 2027 driverless launch projecting $1B ARR at 85% margins

  • Revenue -66% YoY to $6.3M, op expenses +21% to $98.7M, net loss widened to $87.2M from $56.4M, cash -71% QoQ to $71M

  • SmartKem(BEARISH)

    Cash -95% YoY to $374K, assets -74% to $2.3M, equity deficit $3.9M despite revenue +750% to $697K, operating loss widened to $12.8M

Risk Flags(8)

  • Operating cash use $71.9M (worse than $61.1M YoY), total cash+equiv -71% QoQ to $71.2M, stockholders equity $481M but R&D +21% YoY

  • Cash critically low at $374K (-95% YoY), history of losses with anticipated continuation, dependent on third-party fabricators

  • Operating cash flow -414M RMB (-165% from +643M RMB YoY), cash equiv -down to RMB 1.5B, total assets +17% but equity growth masked

  • Oregon revenue -9% to $11M, Michigan -22% to $10M, uncertain tax position +59% to $9.5M, corporate net loss $4.2M

  • $105M fee if CECO fails, $74.7M reverse, fixed exchange ratios (0.8110/0.6840 CECO shares/Thermon share) exposed to market volatility

  • YE2026 close risks include regulatory delays, disruptions, synergies failure, potential rating downgrades

  • Changi Airport +56% YoY to 14% revenue, Klenco +100% to 10%, sales cycles 2-9 months with debt restrictions

  • Audit Chair Drayton failed majority vote in 2025 but renominated amid ongoing material weakness remediation

Opportunities(10)

  • $2.2B liquidity, 12M sq ft leased, assets acquired $248M, buybacks at $19.79 avg vs strong occupancy/credit ratings

  • 380 cargoes shipped, 6 new 20-yr SPAs enabling CP2 FID, safety TRIR 0.17 vs industry 2.2, run-rate 68 MTPA

  • FTC clearance unlocks $21.50/share cash deal, no negative conditions, Offer to Purchase dated Mar 26

  • PlusAI/Business Combo(OPPORTUNITY)

    Q2 2026 SPAC with Churchill IX at peer discount, $40-50M FY2026 revenue target, partnerships with TRATON/Hyundai/Iveco

  • Private proposal to Dioxitek for UF6 facility using existing infra, post-Aug 2025 MOU, aligns with nuclear fuel demand

  • ARPA-E SCALEUP up to $40M for UCS pilot in TX with Westinghouse/Halliburton, NRC cert path for eVinci fuel

  • $2M tranche of $20M commitment supports TAAP/MPAR platforms for abuse-resistant analgesics

  • Adj EBITDA +43% with indoor/pre-roll strength, NJ $6M EBITDA vs Oregon/Michigan declines

  • Vistance Networks/Special Payout(OPPORTUNITY)

    $10/share distribution from asset sale, no leverage added amid debt volatility

  • Q2 2026 Nasdaq listing as pure-play Dogecoin miner, USD/stablecoin conversion in 24hrs

Sector Themes(6)

  • REITs Capital Discipline

    Kimco exemplifies sector strength with 96.4% occupancy, +4% YoY dividends, $248M acquisitions, 6.1M share buybacks at 5.4x leverage (A/A3 ratings) vs broader buyback trends (News Corp $1B program) [POSITIVE; Favor returns-focused REITs]

  • Biotech Cash Pressures

    3/5 biotechs (Nurix -66% rev/-71% cash QoQ, SmartKem -95% cash, Day One M&A exit) show revenue declines/loss widening despite pipelines (Nurix Phase 3 mid-2026); contrasts Ensysce funding [CAUTION; Monitor burn rates]

  • Energy/LNG Boom

    Venture Global +177% rev/+198% EBITDA, Nano Nuclear UF6 JV proposal, Deep Isolation DOE $40M; 68 MTPA capacity target amid global demand [BULLISH; Outperformers vs declining Grown Rogue outdoor -10%]

  • M&A Acceleration

    5 deals advancing (Day One FTC clear, CECO HSR Apr2, Corebridge YE2026, Coeptis Q2, PlusAI Q2) with fixed premiums/ratios, $105M fees as backstops [OPPORTUNITY; Arbitrage plays]

  • Institutional Tech/ETF Tilt

    14 13F-HR show Apple/Amazon/NVIDIA ubiquitous (e.g., Wisconsin Wealth NVIDIA 19k sh, Abacus Amazon $19M), defensive ETFs dominant amid neutral sentiment [STABLE; Megacap safety]

  • Dividend Resilience

    4 declarations (Ellington $0.08 mo, Vistance $10 special, Kimco +4% YoY) signal confidence despite mixed cash flows (ATRenew negative) [POSITIVE; Income strategies]

Watch List(8)

  • Vote on 9 directors, say-on-pay, PwC ratification May 21, 2026; monitor occupancy/dividend sustainability [May 21, 2026]

  • Elect 11 directors, NEO comp, KPMG ratification May 21, 2026 virtual; Zallie Chairman transition [May 21, 2026]

  • Post-FTC clearance, watch other conditions per Mar 26 Offer to Purchase for $21.50/share deal [Q2 2026]

  • Phase 3 DAYBreak CLL-306 mid-2026, bexobrutideg data 2026, IND 2026 despite rev decline [Mid-2026]

  • Stockholder approvals, Nasdaq listing, tax opinion post-HSR Apr2; $105M fee risk [Q2-Q3 2026]

  • Regulatory/shareholder approvals for all-stock deal, $1.5T AUMA scale [YE2026]

  • PlusAI/Churchill IX Combo
    👁

    Q2 2026 close, $40-50M FY2026 rev target, 92% autonomous progress [Q2 2026]

  • 7 directors, E&Y ratification May 27, 2026; CP2 FID from new SPAs [May 27, 2026]

Filing Analyses(50)
E Fund Management (Hong Kong) Co., Ltd.13F-HRneutralmateriality 8/10

08-04-2026

E Fund Management (Hong Kong) Co., Ltd. filed its 13F-HR on April 8, 2026, reporting U.S. equity holdings as of March 31, 2026, with all positions held under sole voting power and no shared or other voting authority indicated. The portfolio features large positions in ETFs and tech stocks, including iShares Core S&P 500 ETF ($29.0B), Apple Inc ($7.2B), Amazon.com Inc ($4.6B), Broadcom Inc ($4.2B), and Meta Platforms Inc ($3.7B). No period-over-period changes or performance metrics are disclosed in this snapshot filing.

  • ·All holdings reported with sole voting power (SH SOLE) and zero shared or other voting authority
  • ·Portfolio includes positions in over 250 U.S.-listed issuers across sectors like technology, mining, healthcare, and ETFs
  • ·SEC file number: 028-20248
  • ·Business address: Suites 3501-02, 35/F Two International Finance Centre, Central, K3 852, Hong Kong
Ingredion IncDEFA14Aneutralmateriality 5/10

08-04-2026

Ingredion Incorporated (INGR) filed DEFA14A additional proxy materials for its 2025 Annual Stockholder Meeting on May 21, 2025, at 8:00 a.m. CDT virtually. Key proposals include electing 11 Board-nominated directors, an advisory vote to approve named executive officer compensation, and ratification of KPMG LLP as independent auditors for the fiscal year ending December 31, 2025. Proxy materials are available online at www.ProxyVote.com, with requests for paper copies due by May 7, 2025.

  • ·Voting deadline: May 20, 2025, 11:59 PM EDT (May 16, 2025, for shares held in a Plan).
  • ·Virtual meeting URL: www.virtualshareholdermeeting.com/INGR2025.
  • ·Request proxy materials: www.ProxyVote.com, 1-800-579-1639, or sendmaterial@proxyvote.com by May 7, 2025.
KIMCO REALTY CORPDEF 14Apositivemateriality 8/10

08-04-2026

Kimco Realty Corp's 2026 DEF 14A Proxy Statement for the May 21, 2026 annual meeting highlights robust 2025 operating performance, including over $2.2 billion in liquidity, pro-rata portfolio occupancy of 96.4% matching all-time highs, and a 4% YoY increase in common dividends to $1.01 per share. The company leased 12 million sq ft across nearly 2,000 leases, repurchased 6.1 million shares at $19.79 average, and acquired assets for $248.1 million total. No material declines noted, with strong balance sheet metrics like 5.4x Net Debt-to-EBITDA and 'A-'/'A3' credit ratings.

  • ·Consolidated Net Debt-to-EBITDA of 5.4x at year-end 2025.
  • ·‘A-’ credit rating from S&P and ‘A3’ from Moody’s.
  • ·Average employee tenure of 10.1 years.
  • ·6 of 9 director nominees are independent; separate Chairman and CEO roles.
ATRenew Inc.20-Fmixedmateriality 9/10

08-04-2026

ATRenew Inc. reported total net revenues of 21,048,256 thousand RMB (3,009,860 thousand US$) for the year ended December 31, 2025, up 28.9% YoY from 16,328,400 thousand RMB, with net product revenues surging 30.6% to 19,379,932 thousand RMB (2,771,293 thousand US$) while net service revenues grew more modestly at 12.5% to 1,668,324 thousand RMB (238,567 thousand US$). The company swung to positive operating income of 456,175 thousand RMB (65,231 thousand US$) and net income of 336,288 thousand RMB (48,088 thousand US$), compared to near-breakeven and small loss in 2024. However, operating cash flow deteriorated sharply to negative 414,569 thousand RMB (59,283 thousand US$) from positive 642,807 thousand RMB, and cash and cash equivalents fell to 1,537,461 thousand RMB (219,854 thousand US$).

  • ·Adjusted net income for 2025 was 428,225 thousand RMB (61,235 thousand US$), up from 314,126 thousand RMB in 2024.
  • ·Total assets as of Dec 31, 2025: 5,965,944 thousand RMB (853,119 thousand US$), down from 5,090,721 thousand RMB in 2024.
  • ·Shareholders' equity as of Dec 31, 2025: 3,990,403 thousand RMB (570,620 thousand US$).
  • ·Workforce breakdown: Operation and Fulfillment 1,430 (59.9%), R&D 449 (18.8%), Sales and Marketing 274 (11.5%).
Ingredion IncDEF 14Aneutralmateriality 6/10

08-04-2026

Ingredion Incorporated's DEF 14A Proxy Statement for the 2026 Annual Meeting on May 20, 2026, seeks stockholder approval to elect 11 director nominees, approve named executive officer compensation on an advisory basis, and ratify KPMG LLP as independent auditors for the fiscal year ending December 31, 2026. James P. Zallie was elected Chairman of the Board in February 2026 in addition to his roles as President and CEO, with Victoria J. Reich appointed as independent Lead Director. The meeting will be held virtually, with a record date of March 23, 2026.

  • ·Virtual annual meeting at www.virtualshareholdermeeting.com/INGR2026, 8:00 a.m. Central Daylight Time
  • ·Record date: March 23, 2026
  • ·Proxy materials available on or about April 8, 2026
Lumentum Holdings Inc.8-Kneutralmateriality 8/10

08-04-2026

Lumentum Holdings Inc. entered into privately-negotiated exchange agreements on April 7, 2026, to issue approximately 5.7 million shares of common stock in exchange for $264.8 million principal amount of 0.50% Convertible Senior Notes due 2026 and $209.8 million principal amount of 1.50% Convertible Senior Notes due 2029, resulting in incremental dilution of approximately 0.6 million shares. Following the exchange, expected to close on or about April 13, 2026, approximately $63.1 million of 2026 Notes and $84.5 million of 2029 Notes will remain outstanding. The transactions are conducted as a private placement exempt under Section 4(a)(2) of the Securities Act, with no cash proceeds to the Company.

  • ·Shares issued pursuant to exemption from registration under Section 4(a)(2) of the Securities Act, offered to accredited investors or qualified institutional buyers.
  • ·Company will receive and cancel the exchanged Notes, with no cash proceeds.
Nurix Therapeutics, Inc.10-Qnegativemateriality 8/10

08-04-2026

Nurix Therapeutics reported total revenue of $6,252 thousand for the three months ended February 28, 2026, a 66% YoY decline from $18,453 thousand, while operating expenses rose 21% YoY to $98,747 thousand driven by higher R&D ($84,137 thousand, +21%) and G&A ($14,610 thousand, +25%), resulting in a net loss of $87,174 thousand versus $56,351 thousand last year. Cash and cash equivalents fell sharply 71% QoQ to $71,195 thousand from $246,960 thousand as of November 30, 2025, amid $71,914 thousand cash used in operations (worse than $61,087 thousand YoY); however, marketable securities increased to $469,537 thousand QoQ and ATM financing provided $17,994 thousand net proceeds. Total assets decreased to $636,130 thousand QoQ from $688,135 thousand, with stockholders' equity at $480,893 thousand.

  • ·Weighted-average shares outstanding: 110,071,668 for Q ended Feb 28, 2026 vs 83,560,795 YoY
  • ·Cash, cash equivalents and restricted cash at end of period: $72,163 thousand (Feb 28, 2026) vs $76,817 thousand (Feb 28, 2025)
  • ·Stock-based compensation expense: $9,404 thousand (Q ended Feb 28, 2026) vs $8,726 thousand YoY
  • ·Net cash used in investing activities: $123,826 thousand (Q ended Feb 28, 2026) vs provided $25,533 thousand YoY
Nurix Therapeutics, Inc.8-Kmixedmateriality 9/10

08-04-2026

Nurix Therapeutics reported first quarter fiscal 2026 financial results with revenue declining 66% YoY to $6.3 million from $18.5 million due to the end of certain Sanofi research terms, while R&D expenses rose 21% to $84.1 million and net loss widened to $87.2 million from $56.4 million. The company maintains a strong cash position of $540.7 million, down from $592.9 million at the prior quarter end, supporting pipeline advancements including ongoing Phase 2 DAYBreak CLL-201 enrollment for bexobrutideg, planned Phase 3 DAYBreak CLL-306 initiation mid-2026, and progress in partnered programs with Sanofi and Gilead. Updated clinical data from bexobrutideg trials are anticipated throughout 2026.

  • ·Phase 2 DAYBreak CLL-201 designed for Accelerated Approval in r/r CLL post cBTKi, BCL-2i, ncBTKi.
  • ·Targeting 2026 IND for bexobrutideg in inflammatory/autoimmune indications with new tablet formulation.
  • ·Sanofi advancing STAT6 degrader NX-3911 in IND-enabling studies; Gilead advancing IRAK4 degrader GS-6791 in Phase 1 healthy volunteers.
A10 Networks, Inc.DEFA14Amixedmateriality 7/10

08-04-2026

A10 Networks' Board issued supplemental proxy disclosures countering Glass Lewis' recommendation to withhold votes for director Eric B. Singer (Proposal 1c) over gender diversity shortfalls (below 30% benchmark) and a prior-year majority withhold vote, while highlighting responsive actions including engagement with shareholders holding 61% of shares, enhanced overboarding disclosures, and rotating the Nominating Committee chair to Peter Y. Chung. The Board also rebuts ISS' against vote on say-on-pay (Proposal 2) regarding former CFO Brian Becker's severance, noting no equity acceleration and ISS' low quantitative pay-for-performance concerns. Despite these advisor oppositions, the Board urges FOR all director nominees and Proposal 2 ahead of the April 22, 2026 Annual Meeting.

  • ·Glass Lewis report dated March 31, 2026
  • ·Nominating Committee chair rotation effective February 11, 2026
  • ·Brian Becker separation date: September 30, 2025
  • ·Proxy Statement originally filed March 10, 2026
  • ·Voting deadline: 11:59 p.m. ET on April 21, 2026
Day One Biopharmaceuticals, Inc.SC 14D9/Apositivemateriality 9/10

08-04-2026

Day One Biopharmaceuticals, Inc. filed Amendment No. 1 to its Schedule 14D-9 on April 8, 2026, announcing that the FTC granted early termination of the HSR Act waiting period on April 7, 2026, at 1:37 p.m. Eastern Time, thereby satisfying the antitrust condition for Servier Detroit Inc.'s cash tender offer to purchase all outstanding shares at $21.50 per share. The offer, pursuant to the March 6, 2026 Merger Agreement, remains subject to other conditions in the Offer to Purchase dated March 26, 2026. No negative developments or unmet conditions are reported in this amendment.

  • ·Premerger Notification and Report Forms filed with FTC and Antitrust Division on March 26, 2026
  • ·Merger Agreement dated March 6, 2026
  • ·Offer to Purchase dated March 26, 2026
Coeptis Therapeutics Holdings, Inc.8-Kpositivemateriality 8/10

08-04-2026

Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) announced that Nasdaq approved, subject to customary conditions and merger closing, the listing of the post-merger company's common stock on the Nasdaq Global Market under ticker 'ZSQR'. This satisfies a key closing condition following the S-4 registration statement effectiveness and shareholder approval on January 30, 2026; the merger with Z Squared Inc. is expected to close in Q2 2026, making Z Squared a wholly-owned subsidiary and changing the company name to Z Squared Inc. No financial metrics or performance comparisons are reported.

  • ·Post-merger, Z Squared expected to be the largest publicly-traded pure-play Dogecoin miner in the United States.
  • ·Merger subject to remaining customary closing conditions.
  • ·Z Squared's model converts mined assets to USD or stablecoins within 24 hours.
Churchill Capital Corp IX/Cayman425neutralmateriality 5/10

08-04-2026

Churchill Capital Corp IX filed a Rule 425 communication accompanying a PlusAI webcast on April 7, 2026, discussing business updates ahead of the proposed business combination between PlusAI and Churchill IX. The presentation includes standard disclaimers, forward-looking statements on topics like market opportunities, technology commercialization, and strategic partnerships (including a non-binding TRATON investment), alongside risks such as technical challenges, net losses, and redemption risks. The related Registration Statement on Form S-4 was declared effective, with a Post-Effective Amendment filed on March 31, 2026, and effective on April 2, 2026.

  • ·Proxy statement/prospectus filed by Churchill IX on January 12, 2026, as amended.
  • ·Churchill IX final prospectus related to IPO filed May 1, 2024.
  • ·Registration Statement File No. 333-290370.
Grown Rogue International Inc.10-Kmixedmateriality 9/10

08-04-2026

Grown Rogue International Inc. reported total revenues of $32,427,936 for the year ended December 31, 2025, up 22% YoY from $26,622,324, with strong growth in Indoor production (+34% to $24,724,109) and Pre-rolls (+57% to $5,162,268), while achieving a net income of $3,229,957 versus a $15,979,351 loss in 2024 and Adjusted EBITDA of $5,385,640 (up from $3,762,446). However, cost of revenues rose 37% to $18,281,254, Outdoor revenue declined 10% to $2,550,095, Services revenue fell 100% to zero, Oregon segment revenue dropped ~9% to $11,059,993, and Michigan revenue decreased ~22% to $10,032,271. Corporate segment posted a $4,179,787 net loss amid higher share-based compensation and other expenses.

  • ·Uncertain tax position balance grew to $9,454,340 as of Dec 31, 2025 from $5,940,429 in 2024.
  • ·Total non-current assets other than financial instruments increased to $35,154,550 as of Dec 31, 2025 from $27,466,557.
  • ·New Jersey Adjusted EBITDA $6,017,762; Oregon $1,158,641; Michigan $3,380,899; Corporate -$5,171,482 for 2025.
  • ·Share-based compensation increased 49% to $2,393,994 in 2025.
Charis Legacy Partners, LLC13F-HRneutralmateriality 4/10

08-04-2026

Charis Legacy Partners, LLC filed its 13F-HR on April 8, 2026, reporting holdings as of March 31, 2026, across 27 positions primarily in Vanguard and iShares ETFs, with select individual stocks. Notable holdings include 182,621 shares of Vanguard STAR FDS VG TL INTL STK F, 54,420 shares of Vanguard BD INDEX FD TOTAL BND MRKT, 86,472 shares of WisdomTree TR FLOATING RAT TREA, 3,741 shares of Apple Inc, and 1,670 shares of Caterpillar Inc. No period-over-period changes, performance metrics, or voting power disparities (all sole discretionary) are indicated in the filing.

  • ·Filing CIK: 0002056602
  • ·Filer address: 4704 Westminster Dr, Bryan, TX 77802
  • ·Business address: 1716 Briarcrest Dr, Suite 300, Bryan, TX 77802
  • ·All positions reported with sole voting and dispositive power (SH SOLE); no shared power indicated
Ensysce Biosciences, Inc.8-Kpositivemateriality 7/10

08-04-2026

Ensysce Biosciences closed a second $2 million convertible preferred stock financing under a November 2025 commitment providing up to $20 million over 24 months to support its flagship analgesic programs and general corporate initiatives. The tranche features a fixed conversion price of $0.55 per share, 100% warrant coverage with an 18-month term, and additional 100% warrant coverage with a five-year term. This funding underscores investor confidence in the company's TAAP and MPAR platforms for abuse- and overdose-resistant pain treatments.

  • ·Alternate conversion price based on average common stock prices prior to conversion.
  • ·Warrants exercisable at fixed conversion price of $0.55 per share, subject to adjustment.
  • ·Announcement date: April 7, 2026; SEC filing date: April 8, 2026.
Wisconsin Wealth Advisors, LLC13F-HRneutralmateriality 4/10

08-04-2026

Wisconsin Wealth Advisors, LLC filed its 13F-HR report on April 8, 2026, disclosing 84 equity holdings totaling $101,653,588 in market value as of March 31, 2026. The portfolio includes individual stocks such as Apple Inc. (8,360 shares), Amazon.com Inc. (9,939 shares), and NVIDIA Corporation (19,833 shares), alongside numerous ETFs from providers like First Trust, Vanguard, and iShares. All positions are held with sole discretionary authority, with no put or call options reported.

  • ·All holdings reported with sole discretionary voting authority and zero put/call shares.
  • ·Report filed as of April 8, 2026, for period ending March 31, 2026.
  • ·Business address: 1777 W Main St, Suite 203, Sun Prairie, WI 53590-3100.
SmartKem, Inc.10-Knegativemateriality 9/10

08-04-2026

SmartKem, Inc. reported revenue of $697 thousand for the year ended December 31, 2025, up 750% YoY from $82 thousand, with gross profit surging to $425 thousand from $50 thousand. However, operating expenses rose 23% to $14,211 thousand, leading to a widened operating loss of $12,835 thousand from $10,464 thousand, a net loss of $10,509 thousand, critically low cash of $374 thousand (down 95% from $7,141 thousand), total assets of $2,288 thousand (down 74% from $8,904 thousand), and stockholders' equity turning to a $3,934 thousand deficit from a $6,591 thousand surplus.

  • ·Net cash used in operating activities improved slightly to $7,736 thousand from $8,096 thousand.
  • ·Company has a history of losses and anticipates continued operating losses.
  • ·Dependence on third-party fabricators for manufacturing, susceptible to delays and pricing fluctuations.
  • ·Filing date: April 08, 2026.
Roberts Wealth Advisors, LLC13F-HRneutralmateriality 5/10

08-04-2026

Roberts Wealth Advisors, LLC filed its 13F-HR on April 8, 2026, disclosing 110 equity positions held solely as of March 31, 2026, totaling 393,912,806 shares with no shared discretion or options. Top holdings by shares include J P Morgan Exchange-Traded F Ultra Short ETF (637,497 shares), J P Morgan Exchange-Traded F Short Dura Core (587,373 shares), and Apple Inc. (92,437 shares), spanning stocks and ETFs across sectors. No prior period data provided for comparisons.

  • ·Filing covers period ending March 31, 2026
  • ·All positions held in sole discretion (no shared or other)
  • ·Headquartered in Palo Alto, CA
  • ·No put or call options reported
Ellington Credit Co8-Kpositivemateriality 6/10

08-04-2026

Ellington Credit Company announced that its Board of Trustees declared a monthly common dividend of $0.08 per share on April 7, 2026. The dividend is payable on May 29, 2026 to common shareholders of record as of April 30, 2026. No comparative financial metrics or changes from prior dividends were disclosed.

  • ·Securities traded on The New York Stock Exchange
  • ·Press release filed as Exhibit 99.1
Emergent Wealth Advisors, LLC13F-HRneutralmateriality 3/10

08-04-2026

Emergent Wealth Advisors, LLC filed its 13F-HR report on April 8, 2026, for the quarter ended March 31, 2026, disclosing 125 equity holdings all managed with sole investment discretion and sole voting authority. The portfolio features significant ETF positions including BlackRock iShares Flexible Income ETF (135,950 shares), iShares Core MSCI EAFE ETF (112,158 shares), and iShares Core MSCI Emerging Markets ETF (111,567 shares), alongside stocks such as NVIDIA Corporation (11,556 shares) and Amazon.com Inc. (8,978 shares). No prior period comparisons, performance metrics, or shared authority positions were reported.

  • ·Business address: 5500 Main St., Suite 260, Williamsville, NY 14221
  • ·Phone: 716-828-8390
  • ·SEC file number: 028-25810
  • ·Value qualifier: 0 (discretionary AUM under $100 million)
  • ·All positions reported as sole discretion with no put/call options or other voting authority
rYojbaba Co., Ltd.20-F/Aneutralmateriality 4/10

08-04-2026

rYojbaba Co., Ltd. (RYOJ) filed a Form 20-F/A amendment to its annual report for the fiscal year ended December 31, 2025, on April 8, 2026. The filing includes newly filed exhibits such as Sarbanes-Oxley Act certifications by the CEO and CFO (Exhibits 12.1, 12.2, 13.1), a Clawback Policy (Exhibit 97.1), and Inline XBRL documents (Exhibits 101.* and 104). Other exhibits, including agreements and policies, are incorporated by reference from prior filings.

  • ·Signed by Takayuki Nakano on April 7, 2026.
  • ·References prior filings: Form 6-K on August 15, 2025; Form F-1 on August 2, 2024; Form 6-K on March 4, 2026; Form 20-F on March 23, 2026.
Uinta Infrastructure Group Corp.S-1neutralmateriality 9/10

08-04-2026

Integrated Rail & Resources Inc. (f/k/a Uinta Infrastructure Group Corp.) filed an S-1 registration statement on April 7, 2026, for an initial public offering of up to an undisclosed number of shares of common stock (par value $0.0001) on the Nasdaq Capital Market tier under the symbol IRRX, with no public market currently existing and listing approval uncertain. The filing also registers for resale 16,260,560 shares of common stock by selling stockholders, including 9,400,000 warrant shares issuable upon exercise of private warrants issued in November 2021. The company qualifies as an emerging growth company and smaller reporting company, with the resale prospectus differing in sections like use of proceeds and selling stockholders.

  • ·Principal executive offices: 400 W. Morse Boulevard, Suite 220, Winter Park, FL 32789; Phone: (321) 972-1583
  • ·Former company name: Uinta Infrastructure Group Corp.; Date of name change: November 7, 2024
  • ·Private warrants issued pursuant to agreement dated November 11, 2021
  • ·SEC file number: 333-294925; EIN: 33-1825873; State of incorporation: Delaware; SIC: 6770
  • ·Underwriters granted 45-day over-allotment option for additional undisclosed shares
Mastech Digital, Inc.8-K/Aneutralmateriality 5/10

08-04-2026

Mastech Digital, Inc. filed an 8-K/A amendment to include Exhibit 10.1, the Restricted Stock Agreement dated March 30, 2026, with CEO and President Nirav Patel for his 2025 annual performance bonus of $616,932 paid in 100,314 restricted shares based on a 30-day VWAP of $6.15. The shares vest immediately but are restricted from disposal until March 30, 2028, subject to exceptions for separation from the Company, death, or disability. This arrangement aligns with Patel's Executive Employment Agreement dated November 1, 2024.

  • ·Restricted Stock Agreement filed as Exhibit 10.1.
  • ·Patel Employment Agreement originally filed as Exhibit 10.1 to 8-K on December 16, 2024.
Ausbil Investment Management Ltd13F-HRneutralmateriality 5/10

08-04-2026

Ausbil Investment Management Ltd filed its 13F-HR report on April 8, 2026, disclosing $201,000,898 in discretionary holdings across 63 positions as of March 31, 2026. Top holdings include H2O America ($14,275,840), NextEra Energy Inc ($13,096,864), and CSX Corp ($10,820,398), with a focus on utilities, energy, transportation, and industrials. The portfolio includes long positions and put options on BHP Group Ltd (40,000 shares), Freeport-McMoRan Inc (50,000 shares), and VanEck Gold Miners ETF (20,000 shares).

  • ·Put options: BHP Group Ltd (value 12000, 40000 shares), Freeport-McMoRan Inc (value 22000, 50000 shares), VanEck Gold Miners ETF (value 8000, 20000 shares)
  • ·All positions reported as SOLE ownership
  • ·Report filed for period ending 2026-03-31
Churchill Capital Corp IX/Cayman425positivemateriality 9/10

08-04-2026

PlusAI provided a business update webcast on April 7, 2026, highlighting commercial freight operations in Texas with Ryder and International Motors achieving 92% autonomous route coverage (targeting high 90s), partnerships with TRATON, Hyundai, and Iveco for factory-installed SuperDrive, and $25M in HyperFoundry contracted revenue YTD with $40-50M targeted for FY2026. The company affirmed readiness for a 2027 driverless commercial launch projecting $1B annual recurring revenue from SuperDrive in 5 years at $40K per truck annually and 85% gross margins, while planning a Q2 2026 public debut via business combination with Churchill Capital Corp IX at a discount to peers. No declines or flat metrics were reported, with forward-looking projections emphasizing path to cash-flow positivity in 2027.

  • ·Operations include daily 600-mile freight routes along I-35 corridor in Texas with less than 30-minute pre-trip inspections and improved fuel efficiency.
  • ·Pipeline includes conversations with 3 of the top 5 dedicated contract fleets and expectations for at least two more fleet customers this quarter.
  • ·Data set spans 4 continents, augmented by simulation and synthetic data.
CECO ENVIRONMENTAL CORPS-4mixedmateriality 9/10

08-04-2026

CECO Environmental Corp has filed an S-4 registration statement as a joint proxy statement/prospectus for its proposed mergers with Thermon Group Holdings, Inc., subject to conditions including stockholder approvals, HSR Act clearance (terminated early on April 2, 2026), Nasdaq listing, and a tax opinion confirming reorganization status under Section 368(a). Key risks include potential failure to close leading to termination fees of $105.0M (CECO to Thermon) or $74.7M (Thermon to CECO), business restrictions pre-closing, market fluctuations affecting stock consideration value (fixed exchange ratios of 0.8110 or 0.6840 shares per Thermon share), proration mechanics altering elected consideration forms, and litigation risks. Thermon stockholders face uncertainty in tax consequences and trading restrictions on elected shares until closing.

  • ·HSR Act waiting period terminated early by FTC effective April 2, 2026
  • ·Stock exchange ratios: 0.8110 shares of CECO common stock for stock consideration; 0.6840 shares plus $10.00 cash for mixed consideration, per Thermon share
  • ·Closing conditions include CECO stockholder approval of stock issuance, Thermon stockholder adoption of merger agreement, effectiveness of S-4, Nasdaq listing of new shares, and tax opinion from Sidley Austin LLP (or Gibson, Dunn & Crutcher LLP) on Section 368(a) reorganization qualification
  • ·Merger agreement restricts business conduct pre-closing, including limits on acquisitions, indebtedness, capital expenditures, and dividends
  • ·Thermon election shares restricted from trading between election submission and closing or revocation
CommScope Holding Company, Inc.8-Kpositivemateriality 8/10

08-04-2026

Vistance Networks (NASDAQ: VISN) Board of Directors approved a special cash distribution of $10.00 per share, payable on April 27, 2026, to holders of record as of April 17, 2026. The distribution will be funded using cash on hand, including proceeds from the January 9, 2026 sale of its Connectivity and Cable Solutions business to Amphenol Corporation. The company cited debt market volatility as the reason for avoiding additional leverage.

  • ·Announcement date: April 7, 2026
  • ·Record date: April 17, 2026
  • ·Payment date: April 27, 2026
  • ·Business sale date: January 9, 2026
Hyliion Holdings Corp.DEF 14Aneutralmateriality 6/10

08-04-2026

Hyliion Holdings Corp. has issued a proxy statement for its virtual 2026 Annual Meeting on May 19, 2026, seeking stockholder approval to elect three directors to serve until 2029, ratify Grant Thornton LLP as independent auditors for the fiscal year ended December 31, 2026, approve named executive officers' compensation on an advisory basis, and amend the 2024 Equity Incentive Plan to increase available common shares by 8 million. As of the record date March 25, 2026, 178,317,154 shares of common stock were outstanding entitled to vote. No financial performance metrics, period-over-period changes, or compensation figures are quantified in the provided filing content.

  • ·Proxy materials first made available to stockholders on April 2, 2026.
  • ·Annual Meeting accessible only online at https://www.cstproxy.com/hyliion/2026.
  • ·Record date for voting eligibility: March 25, 2026.
Nano Nuclear Energy Inc.8-Kpositivemateriality 7/10

08-04-2026

Nano Nuclear Energy Inc. submitted a private proposal to Dioxitek S.A., an Argentinian state-owned nuclear fuel company, for the potential joint development of a natural uranium hexafluoride (UF6) production facility using Dioxitek's existing infrastructure in Argentina. This follows a non-binding Memorandum of Understanding executed in August 2025 to assess uranium conversion capacities. The proposal is under review per Argentinian law, with ongoing coordination for technical, financial, and implementation assessments toward potential definitive agreements, though forward-looking statements note significant risks including regulatory approvals and execution uncertainties.

  • ·Filing date: April 08, 2026; Earliest event date: April 7, 2026
  • ·Dioxitek described as Argentina's only feedstock manufacturer for nuclear fuel fabrication
SpringBig Holdings, Inc.8-Kneutralmateriality 6/10

08-04-2026

On April 1, 2026, SpringBig Holdings, Inc. entered into a formal three-year Employment Agreement with CEO Jaret Christopher, superseding his prior offer letter, featuring a $450,000 annual base salary, 50% target cash bonus opportunity, and a grant of 12,891,251 restricted common stock shares (with approximately 8,320,939 vesting immediately). The Board also approved compensation for independent Director Larry Ellis, including 1,193,623 RSUs vesting over three years and cash retainers of $60,000 one-time plus $10,000 monthly; additionally, retention bonuses were set for CFO Jason Moos (1,907,229 phantom units and $165,000 cash) and COO James Cabral (1,056,824 phantom units and $110,000 cash), payable upon a Change in Control.

  • ·CEO Employment Agreement includes 12 months post-employment noncompetition and nonsolicitation covenants.
  • ·Director Larry Ellis RSUs subject to 100% acceleration upon Change in Control if service terminated in connection therewith.
  • ·CEO RSUs vest in equal quarterly installments over approximately three years, with acceleration on qualifying terminations.
  • ·Ellis appointed to Board on September 24, 2025; prior CEO offer letter dated March 13, 2025.
Longboard Asset Management, LP13F-HRneutralmateriality 3/10

08-04-2026

Longboard Asset Management, LP reported 28 equity holdings totaling $5,787,788 as of March 31, 2026, in its 13F-HR filing. The portfolio features top positions in utilities such as Alliant Energy Corporation ($252,739 value, 3,522 shares), Aflac Inc. ($252,552 value, 2,302 shares), and FirstEnergy Corporation ($252,236 value, 4,979 shares), alongside multiple REITs including InvenTrust Properties Corp ($230,643, 7,572 shares). All holdings are with sole voting power and no reported shared discretion.

  • ·Filing date: April 08, 2026
  • ·Report period end: March 31, 2026
  • ·All 28 positions held with sole voting power (SH SOLE); no shared power or other managers reported
  • ·Portfolio heavily weighted toward utilities and REITs
NEWS CORP8-Kneutralmateriality 4/10

08-04-2026

News Corporation disclosed via 8-K information provided to the Australian Securities Exchange (ASX) on recent dates regarding its ongoing stock repurchase program, authorized for up to $1 billion in aggregate repurchases of Class A (NWSA) and Class B (NWS) common stock. The filing references Exhibits 99.1 and 99.2 containing these ASX disclosures and includes forward-looking statements on repurchase intentions, subject to market conditions and other factors. No specific repurchase volumes or transactions are detailed in the main filing content.

  • ·Securities: Class A Common Stock (NWSA, par value $0.01), Class B Common Stock (NWS, par value $0.01), both on Nasdaq Global Select Market
  • ·Date of earliest event reported: April 7, 2026
  • ·Filing signed and dated: April 8, 2026
Corebridge Financial, Inc.425mixedmateriality 10/10

08-04-2026

Corebridge Financial has entered a definitive all-stock merger agreement with Equitable Holdings to create a leading retirement, life, wealth, and asset management company with over 12 million customers and $1.5 trillion in assets under management and administration. The merger is expected to enhance capabilities for CREI by leveraging AllianceBernstein’s global distribution, with closure targeted by year-end 2026 subject to regulatory and shareholder approvals. While the transaction offers potential synergies and scale, it carries significant risks including integration challenges, failure to obtain approvals, business disruptions, and potential adverse impacts on operations and stock price.

  • ·Transaction to close by year-end 2026, subject to customary closing conditions including regulatory approvals and shareholder votes.
  • ·Corebridge and Equitable to operate separately until closing, with no changes to CREI partner contacts.
  • ·Forward-looking statements highlight risks such as integration difficulties, failure to realize synergies, business disruptions, and potential rating downgrades.
Onfolio Holdings, Inc8-Kneutralmateriality 8/10

08-04-2026

Onfolio Holdings Inc. issued a press release on March 31, 2026, announcing its financial results for the full year ended December 31, 2025, with the Annual Report on Form 10-K filed on the same date. The earnings call transcript for Full Year 2025 was posted to the company's website on April 7, 2026. No specific financial metrics are detailed in this 8-K filing.

  • ·10-K filed with SEC on March 31, 2026, available at www.sec.gov and https://investors.onfolio.com/filings
  • ·Earnings call transcript available at https://investors.onfolio.com/events
  • ·Securities: Common Stock (ONFO), Warrants (ONFOW) on Nasdaq Capital Market
Boltwood Capital Management13F-HRneutralmateriality 6/10

08-04-2026

Boltwood Capital Management disclosed $392,066,630 in total equity holdings across 184 positions in its 13F-HR filing as of March 31, 2026. The portfolio features heavy allocations to ETFs including FlexShares iBoxx 3R Target ($21.9M), various iShares Treasury and international equity funds, SPDR sector ETFs, and individual names such as Apple ($9.6M), NVIDIA ($9.4M), and Microsoft ($7.1M). No period-over-period changes are available in this filing.

  • ·Report period end: March 31, 2026
  • ·Filing date: April 8, 2026
  • ·All holdings reported as sole discretionary (SH SOLE)
Abacus Planning Group, Inc.13F-HRneutralmateriality 4/10

08-04-2026

Abacus Planning Group, Inc. disclosed its quarterly 13F-HR holdings totaling $742,886,732 across 264 positions as of March 31, 2026, all held with sole voting and discretionary power. Top holdings include ETF Ser Solutions Distillate US Fund at $82,956,949 (11.2% of portfolio), iShares TR 0-5 YR TIPS ETF at $62,294,699, and Amazon.com Inc. at $19,463,665. The portfolio features heavy allocations to ETFs (e.g., Dimensional, Schwab Strategic, iShares) including Bitcoin, gold, silver, and fixed income products, alongside individual stocks like Apple Inc. ($13,898,799).

  • ·Filing submitted April 8, 2026, for period ending March 31, 2026.
  • ·All 264 positions held as sole discretionary accounts with sole voting power.
  • ·Notable exposure to commodities/alt assets: Sprott Physical Silver ($13,786,813), Sprott Physical Gold ($6,056,164), iShares Silver TR ($963,568).
MB, LEVIS & ASSOCIATES, LLC13F-HRneutralmateriality 4/10

08-04-2026

MB, Levis & Associates, LLC filed its 13F-HR on April 8, 2026, disclosing a portfolio valued at $239,680,085 across 234 positions as of March 31, 2026. Notable holdings include Vanguard Index FDS Large Cap ETF at $19,767,506, Vanguard Intl Equity Index F Allworld Ex US at $19,962,080, and WisdomTree TR US Qtly Div Grt at $15,315,334, with all positions held solely by the filer. The filing provides a snapshot of diversified investments in stocks, ETFs, and fixed income without period-over-period comparisons.

  • ·Filer address: 4647 Saucon Creek Road, Suite 101, Center Valley, PA 18034
  • ·Report period end: 03-31-2026
  • ·Filing date: 04-08-2026
  • ·All holdings reported as SOLE ownership with no put/call or other managers
Pathway Financial Advisors LLC13F-HRneutralmateriality 5/10

08-04-2026

Pathway Financial Advisors LLC disclosed total holdings of $808,291,858 across 136 positions, all held solely, as of March 31, 2026, in its 13F-HR filing. The portfolio is dominated by ETFs including Vanguard Index Fds Value ETF ($105,147,546, 533,771 shares), Goldman Sachs ETF Tr Access Treasury ($95,761,766, 958,193 shares), and Vanguard Index Fds Growth ETF ($90,967,061, 205,794 shares). Individual stocks such as Apple Inc ($3,998,642, 15,625 shares), Microsoft Corp ($2,559,695, 6,854 shares), and NVIDIA Corp ($1,648,511, 9,293 shares) represent smaller but notable allocations.

  • ·All 136 positions held with sole investment discretion (SH SOLE); no shared or performance rights.
  • ·Filing CIK: 0001738828; SEC file number: 028-18736.
  • ·Headquartered in South Burlington, VT.
Venture Global, Inc.DEFA14Aneutralmateriality 3/10

08-04-2026

Venture Global, Inc. filed Definitive Additional Proxy Materials (DEFA14A) with the SEC on April 08, 2026. This filing supplements prior proxy statements pursuant to Section 14(a) of the Securities Exchange Act of 1934. No specific proposals, financial data, or governance details are provided in the filing header.

  • ·Filing Type: DEFA14A (Definitive Additional Materials)
  • ·Filed by the Registrant
Venture Global, Inc.DEF 14Apositivemateriality 9/10

08-04-2026

Venture Global's 2026 proxy statement highlights exceptional 2025 performance, exceeding all operational targets with revenue of $13.8 billion (177% YoY increase from FY 2024), income from operations of $5.2 billion (192% increase), net income of $2.3 billion (53% increase), and Consolidated Adjusted EBITDA of $6.3 billion (198% increase); total assets reached $53.4 billion, up $10.0 billion from $43.5 billion at year-end 2024. The statement proposes election of seven director nominees (including five independents) and ratification of Ernst & Young LLP as independent auditors for 2026, ahead of the virtual annual meeting on May 27, 2026. Operational achievements include shipping 380 LNG cargoes, signing six 20-year LNG SPAs enabling CP2 Phase I FID, and industry-leading safety with a 0.17 Total Recordable Incident Rate versus the industry average of 2.2.

  • ·Favorable resolutions in Calcasieu Pass arbitrations, including no-liability decisions with Shell (August 2025) and Repsol (January 2026), reaffirmed by New York State Supreme Court (March 2026).
  • ·Annual meeting record date: March 30, 2026.
  • ·Anticipated annual run-rate capacity of 68 MTPA from Calcasieu Pass, Plaquemines Phases 1 & 2, and CP2 Phases 1 & 2 upon completion.
  • ·Plans for additional 13 MTPA bolt-on capacity at CP2 and Plaquemines.
  • ·Five of seven director nominees are independent per NYSE rules.
Central Pacific Bank - Trust Division13F-HRneutralmateriality 4/10

08-04-2026

Central Pacific Bank - Trust Division filed Form 13F-HR on April 08, 2026, disclosing 970 equity holdings as of March 31, 2026, with a total portfolio value of $783638357. The portfolio features positions in major companies including Apple Inc. (5868072065 shares defined), Alphabet Inc., Amazon.com Inc., and hundreds of others across sectors like technology, healthcare, and consumer goods. This is a routine quarterly holdings report with no explicit period-over-period changes detailed.

  • ·Filing date: April 08, 2026
  • ·Period end date: March 31, 2026
  • ·State of incorporation: HI
  • ·Fiscal year end: 12/31
  • ·SEC file number: 028-24090
  • ·Contact phone: 8085446808
MYECFO, LLC13F-HRneutralmateriality 4/10

08-04-2026

MYECFO, LLC filed its 13F-HR report on April 8, 2026, disclosing 66 equity holdings as of March 31, 2026, primarily consisting of ETFs from Schwab Strategic Trust, Vanguard, and iShares, along with individual stocks in tech and other sectors. The portfolio's largest position is SCHWAB STRATEGIC TR US BRD MKT ETF valued at $64193818, followed by VANGUARD TAX-MANAGED FDS VAN FTSE DEV MKT at $29167578 and ISHARES TR CALIF MUN BD ETF at $14928154. No period-over-period changes are provided in the filing.

  • ·Report period end date: March 31, 2026
  • ·Filer CIK: 0001986457
  • ·SEC file number: 028-23324
  • ·Business address: 6020 La Jolla Hermosa Ave, La Jolla, CA 92037
Scorpius Holdings, Inc.8-Kneutralmateriality 7/10

08-04-2026

William Ostrander, Chief Financial Officer of Scorpius Holdings, Inc., notified the company of his resignation effective March 31, 2026, on March 29, 2026. Mr. Ostrander did not indicate any disagreement with the company regarding operations, policies, or practices. The 8-K filing, dated April 8, 2026, was signed by Jeffrey Wolf, Chairman, President, and Chief Executive Officer.

  • ·Date of earliest event reported: March 29, 2026
  • ·Resignation effective date: March 31, 2026
  • ·Filing submitted pursuant to Items 5.02 and 9.01 of Form 8-K
MVB FINANCIAL CORP8-Kneutralmateriality 6/10

08-04-2026

MVB Financial Corp announced the appointment of Michael L. Giorgio as Chief Operating Officer for the company and its wholly-owned subsidiary MVB Bank, Inc., effective April 1, 2026, in addition to his existing role as Chief Information Officer. No changes were made to Mr. Giorgio's employment agreement, compensation, or any other arrangements in connection with this appointment. Mr. Giorgio has no family relationships with directors or executives and no material interests in transactions requiring disclosure.

  • ·Biographical information for Mr. Giorgio incorporated by reference from the company's definitive proxy statement filed April 7, 2026.
  • ·Event reported on Form 8-K filed April 8, 2026, covering Items 5.02 and 9.01.
Deep Isolation Nuclear, Inc.8-Kmixedmateriality 8/10

08-04-2026

Deep Isolation Nuclear, Inc. announced its selection for the U.S. Department of Energy’s ARPA-E SCALEUP Ready program to advance commercial deployment of its Universal Canister System for nuclear waste management, with the program committing up to $40 million across two projects. The project involves a commercial pilot in Cameron, Texas, with partners including Westinghouse, Halliburton, NAC International, Occlusion Nuclear Solutions, Amentum, and the Deep Borehole Demonstration Center. However, selection does not guarantee funding, as DOE may cancel negotiations at any time, and there is no assurance of a contract, funding amount, or successful completion of deliverables.

  • ·Westinghouse will serve as launch customer to secure NRC certification for UCS with eVinci™ microreactor spent fuel.
  • ·Project aligns with Executive Order 14302 on U.S. nuclear energy leadership and permanent spent fuel solutions.
  • ·UCS developed through prior three-year DOE ARPA-E funded project.
KIMCO REALTY CORPDEFA14Aneutralmateriality 7/10

08-04-2026

Kimco Realty Corporation issued definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting on May 21, 2026, held virtually at 10:00 a.m. ET. Shareholders are voting on the election of nine director nominees (Ross Cooper, Philip E. Coviello, Conor C. Flynn, David Jamieson, Nancy Lashine, Henry Moniz, Mary Hogan Preusse, Valerie Richardson, Richard B. Saltzman), an advisory resolution approving executive compensation, and ratification of PricewaterhouseCoopers LLP as independent auditors for the year ending December 31, 2026, with the board recommending FOR all proposals. Proxy materials are available online at www.ProxyVote.com, with voting deadline of 11:59 p.m. ET on May 20, 2026.

  • ·Meeting format: Virtual only at www.virtualshareholdermeeting.com/KIM2026
  • ·Vote by phone/mail: Request paper copy by May 7, 2026
  • ·For shares in a Plan: Vote by 11:59 p.m. ET on May 15, 2026
  • ·Filed: April 08, 2026
Shattuck Labs, Inc.DEFA14Aneutralmateriality 6/10

08-04-2026

Shattuck Labs, Inc. has filed definitive additional proxy materials (DEFA14A) for its Annual Meeting of Stockholders on May 28, 2026, at 11:30 AM Eastern Time, held live via the internet at www.proxydocs.com/STTK. Key proposals include electing three Class III directors (Taylor Schreiber, M.D., Ph.D., Helen M. Boudreau, and Clay Siegall, Ph.D.) to serve until the 2029 Annual Meeting, ratifying KPMG LLP as independent auditors for the year ending December 31, 2026, an advisory vote to approve named executive officer compensation, an advisory vote on the frequency of future say-on-pay votes (Board recommends 1 year), and approving an amendment and restatement of the 2020 Equity Incentive Plan. Stockholders of record as of April 2, 2026, can access full materials online or request paper copies by May 18, 2026.

  • ·Board recommends voting 'FOR' each director nominee in Proposal 1, 'FOR' Proposals 2, 3, and 5, and '1 YEAR' on Proposal 4.
  • ·Proxy materials available at www.proxydocs.com/STTK; requires 12-digit control number to vote or register.
  • ·No fee required for filing; paper requests via www.investorelections.com/STTK, 1-866-648-8133, or paper@investorelections.com.
3D SYSTEMS CORPDEF 14Amixedmateriality 7/10

08-04-2026

3D Systems' 2026 Proxy Statement proposes the election of nine current directors for one-year terms, including retaining Audit Committee Chair Ms. Drayton despite her failing to receive a majority of votes at the 2025 Annual Meeting, citing her critical role in overseeing remediation of material weaknesses in internal controls. The Board reports substantial progress in 2025 on remediating most material weaknesses without any financial restatements, under Ms. Drayton's leadership. Other proposals include an advisory vote on 2025 Named Executive Officer compensation, ratification of auditors, increasing authorized common shares, and amending the 2015 Incentive Plan.

  • ·Annual Meeting scheduled for May 14, 2026 via live webcast at www.proxydocs.com/DDD
  • ·2025 Annual Report on Form 10-K filed with SEC on March 9, 2026
  • ·Ms. Drayton appointed Audit Committee Chair eight months into 2024 fiscal year
  • ·Majority vote required for uncontested director elections per By-Laws
SIMPPLE LTD.20-Fmixedmateriality 6/10

08-04-2026

SIMPPLE LTD. (SPPL) filed its 20-F Annual Report on April 08, 2026, revealing customer concentration risks with no single customer exceeding 14% of revenue in FY2025, up from SMRT Corporation's 38% in FY2023 which fell to 0%. Changi Airport Group increased its share to 14% in FY2025 from 9% in FY2024 (+55.6% YoY), and Klenco rose to 10% from 5% (+100% YoY), while Weishen Industrial Services declined sharply to 2% from 8% (-75% YoY). The report details product sales cycles ranging from 2-3 to 9 months and highlights risks such as debt restrictions, stock volatility, and future funding needs.

  • ·SIMPPLE Vision sales conversion cycle: 5 to 6 months
  • ·SIMPPLE Integrate sales conversion cycle: 6 months
  • ·SIMPPLE Compute sales conversion cycle: 9 months
  • ·SIMPPLE Evolve sales conversion cycle: 2 to 3 months
  • ·Regulatory agencies referenced: BCA, IRAS, ISO, JTC, MOM, NEA, URA

Get daily alerts with 12 investment signals, 8 risk alerts, 10 opportunities and full AI analysis of all 50 filings

🇺🇸 More from United States

View all →
US SEC Filings Daily Market Digest — April 08, 2026 | Gunpowder Blog